FMS in “GLP-1 Eats Everything”
Fresenius Medical Care AG
Broad GLP-1 adoption could eventually reduce diabetes-driven kidney disease and pressure long-term growth in dialysis treatment volumes.
FMS impact map — “GLP-1 Eats Everything”
How this story travels from the headline to FMS’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading FMS impact map…
Price history, marked with story events
Aug 25, 2025 – Aug 26, 2026 · 253 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BEAR side — Broad GLP-1 adoption could eventually reduce diabetes-driven kidney disease and pressure long-term growth in dialysis treatment volumes.
Read the full GLP-1 Eats Everything story